Acquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
ALLOSENSITIZATION PROFILING REAGENTSAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
REAGENTS FOR CHARACTERIZATION OF THE ANTI-HLA ALLOSENSITIZATION PROFILE AND THAT DEFINE THE ACTIVATION OF THE COMPLEMENT C1Q FRACTIONAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
ALLOSENSITIZATION PROFILING REAGENTSAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
CONTROL REAGENTS FOR MICROCYTOTOXICITY REACTIONSAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
COLORING REAGENTS FOR MICROCYTOTOXICITY REACTIONSAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
REAGENTS FOR MICROCYTOTOXICITY REACTIONSAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
REAGENTS FOR PARAFFINING TERASAKI MICROPLATESAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
REAGENTS FOR CHARACTERIZATION OF ANTI HLA ALLOSENSITIZATION PROFILE AND DEFINING THE ACTIVATION OF COMPLEMENT C3D FRACTIONAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.
REAGENTS FOR IDENTIFICATION OF NON-HLA ANTIBODIESAcquisition of REAgents for Definition of HLA Allosensitization in Clinical Histocompatibility, for the HLA Serology Laboratories (Transplantation Area), ipst, IP, during the year 2022.